Orion Development Group is a privately owned speciality pharmaceutical company. Orion is focused on the design, development, and commercialization of pharmaceuticals based on dietary supplement ingredients using a novel idea for expediting the FDA approval process conceived by its founder.
This process may significantly reduce both the time and money needed for FDA approval.
Orion is currently pursuing this approval process having identified six drug formulations with a combined sixteen potential indications on which to focus its efforts. The company seeks to identify additional formulations suitable for this process.